Biodel

Biodel's insulin drug found effective in trial
Biodel's insulin drug found effective in trial
Yahoo/Reuters
Biodel
insulin
diabetes
BIOD-531
Flag link:
Eight Biotech Stocks Trading Near $5 With Huge Upside Potential
Eight Biotech Stocks Trading Near $5 With Huge Upside Potential
24/7 Wall St
Array Biopharma
Biodel
Galena Biopharma
Novavax
Protalix BioTherapeutics
Rigel Pharmaceuticals
Synta Pharmaceuticals
Zogenix
Flag link:
Biodel Inc: Strong Biotech 'January Effect' Candidate For 2014
Biodel Inc: Strong Biotech 'January Effect' Candidate For 2014
Seeking Alpha
Biodel
insulin
diabetes
Flag link:
Biodel up 10.5 percent premarket after supply agreement with Becton Dickinson
Biodel up 10.5 percent premarket after supply agreement with Becton Dickinson
Reuters
Biodel
Becton Dickinson
Flag link:
Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy
Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy
Seeking Alpha
Biodel
insulin
diabetes
BIOD-123
Flag link:
Biodel's BIOD-123 Achieves Primary Endpoint in Phase 2 Clinical Trial Demonstrating Glycemic Control Comparable to Humalog(R)
Biodel's BIOD-123 Achieves Primary Endpoint in Phase 2 Clinical Trial Demonstrating Glycemic Control Comparable to Humalog(R)
Yahoo
Biodel
BIOD-123
clinical trials
diabetes
type 1 diabetes
Flag link:
Is This a MannKind Killer?
Is This a MannKind Killer?
Motley Fool
MannKind
diabetes
Afrezza
BIOD-123
insulin
Biodel
Flag link:
[video] Biotech's Next Big Thing: Fall Trials
[video] Biotech's Next Big Thing: Fall Trials
TheStreet.com
clinical trials
Biodel
Coronado Biosciences
Achillion
BIOD-531
hepatitis C
pig whip worms
Flag link:
Our BioPharma Catalyst Watch List
Our BioPharma Catalyst Watch List
Seeking Alpha
Astex
Biodel
Insmed
MannKind
Onconova
Afrezza
Dacogen
Arikace
Rigosertib
Flag link:
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Seeking Alpha
GLP-1 agonist
diabetes
Oramed
Biodel
Bristol-Myers Squibb
Eli Lilly
MannKind
Novo Nordisk
Merck
Afrezza
Januvia
Victoza
Flag link:
Why Biodel Will Have Positive Phase II Results
Why Biodel Will Have Positive Phase II Results
Seeking Alpha
Biodel
BIOD-123
type 1 diabetes
type 2 diabetes
diabetes
Flag link:
BioPharma Catalyst Trade Pick Of The Week: Biodel
BioPharma Catalyst Trade Pick Of The Week: Biodel
Seeking Alpha
MannKind
Eli Lilly
Biodel
Astex
Flag link:
3 Biotech Catalysts Primed To Be Successful In Q3
3 Biotech Catalysts Primed To Be Successful In Q3
Seeking Alpha
BIOD-123
Biodel
MannKind
Afrezza
GTx
Flag link:
Unilife: Taking Positions Ahead Of A Key Fiscal Year
Unilife: Taking Positions Ahead Of A Key Fiscal Year
Seeking Alpha
Unilife
Biodel
Flag link:
Biodel: A Biotech Company Weathering The Volatility
Biodel: A Biotech Company Weathering The Volatility
Seeking Alpha
Biodel
Flag link:
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
Flag link:
The Run-Up Trade: Biodel's Insulin Trial Results
The Run-Up Trade: Biodel's Insulin Trial Results
TheStreet.com
insulin
diabetes
Biodel
BIOD-123
MannKind
Afrezza
Flag link:
Biodel: Reemerging From Obscurity In 2013
Biodel: Reemerging From Obscurity In 2013
Seeking Alpha
Biodel
Eli Lilly
BIOD-123
recombinant human insulin
BIOD-250
Flag link:
Biodel's CEO Discusses F3Q12 Results - Earnings Call Transcript
Biodel's CEO Discusses F3Q12 Results - Earnings Call Transcript
Seeking Alpha
Biodel
earnings
Flag link:
Biodel raises $18.5M in a private placement
Biodel raises $18.5M in a private placement
The Fly on the Wall
Biodel
Flag link:

Pages